Myositis
Myositis-specific antibodies a ‘powerful tool’ for diagnosis, management
DESTIN, Fla. — Understanding which autoantibodies are present in patients with myositis can help with both diagnosis and treatment, according to a presenter at the 2023 Congress of Clinical Rheumatology-East.
‘Exciting time for myositis’: Drug pipeline shifts from organ-centric to targeted therapy
DESTIN, Fla. — Although new targets and therapies are on the horizon, current myositis treatment strategies rely on treating impacted organ groups, according to a speaker at the 2023 Congress of Clinical Rheumatology-East.
‘Quite reassuring’: Nearly 75% of YouTube videos on myositis provide useful information
Approximately 74% of YouTube videos on myositis provide useful information, with nearly half of useful videos created by professional medical societies or patient support groups, according to data published in Clinical Rheumatology.
‘Poorly understood’ and rife with mimics: Rheum-neuro diseases require a team approach
For all the multitudes of diseases and diversity of organ systems rheumatologists are adept at managing and analyzing, the brain, spinal cord and related neurological conditions are often not among them.
Polymyositis diagnoses ‘exceedingly rare’ in shift toward inclusion body myositis
SAN DIEGO — Many patients who might have previously been diagnosed with polymyositis are now being treated for inclusion body myositis, according to a speaker at the Congress of Clinical Rheumatology West.
Myositis pain strategies ‘not uniform,’ require ‘multiple modalities’
Among patients with myositis, younger individuals with dermatomyositis are more likely to experience pain, while those with polymyositis are more likely to receive opioids, according to data published in Rheumatology.
Immunosuppressants remain ‘cornerstone’ therapy for CTD-ILD as drug options emerge
Although immunosuppressives remain the cornerstone for managing underlying interstitial lung disease in connective tissue diseases, new drug approvals could help shift the treatment paradigm, according to data presented here.
Cancer screening recommendations in autoimmune disease rely on experience in lieu of data
Cancer screening recommendations for patients with autoimmune diseases largely rely on clinical experience and extrapolation in the absence of abundant data, according to a speaker at the 2021 Congress of Clinical Rheumatology-East meeting.
ECMO consideration recommended for myositis-associated rapidly progressive ILD
Among patients with myositis-associated rapidly progressive interstitial lung disease, extracorporeal membrane oxygenation was well tolerated with no deaths from direct complications, according to a case series published in Chest.
Extensive assessment critical to dispel 'ambiguity' mimics in juvenile dermatomyositis
Juvenile dermatomyositis challenges rheumatologists to accurately assess not only the skin but also pulmonary and cardiac function in making a diagnosis, according to a speaker at the 2021 Rheumatology Nurses Society annual conference.